InsiderClue
Insiders · Profile

Bredt David

Chief Scientific Officer at Rapport Therapeutics. Filing since 14 Mar 2025. CIK 0002022087

Company
Date
Role
Action
Shares
Amount
Of holding
RAPP Rapport Therapeutics, Inc.
17 Feb 2026
Chief Scientific Officer
Sold on a plan
8,500
$246.66K
2.1%
RAPP Rapport Therapeutics, Inc.
15 Jan 2026
Chief Scientific Officer
Sold on a plan
8,500
$228.13K
2.1%
RAPP Rapport Therapeutics, Inc.
31 Dec 2025
Chief Scientific Officer
Sold at will
6,567
$197.34K
1.6%
RAPP Rapport Therapeutics, Inc.
15 Dec 2025
Chief Scientific Officer
Sold on a plan
8,500
$255.13K
2.1%
RAPP Rapport Therapeutics, Inc.
17 Nov 2025
Chief Scientific Officer
Sold on a plan
8,500
$214.09K
2.1%
RAPP Rapport Therapeutics, Inc.
15 Oct 2025
Chief Scientific Officer
Sold on a plan
8,500
$219.20K
2.0%
RAPP Rapport Therapeutics, Inc.
15 Sep 2025
Chief Scientific Officer
Sold on a plan
8,500
$205.65K
2.0%
RAPP Rapport Therapeutics, Inc.
15 Aug 2025
Chief Scientific Officer
Sold on a plan
8,500
$127.47K
2.0%
RAPP Rapport Therapeutics, Inc.
15 Jul 2025
Chief Scientific Officer
Sold on a plan
8,500
$118.96K
1.9%
RAPP Rapport Therapeutics, Inc.
16 Jun 2025
Chief Scientific Officer
Sold on a plan
8,500
$93.52K
1.9%
RAPP Rapport Therapeutics, Inc.
15 May 2025
Chief Scientific Officer
Sold on a plan
8,500
$81.26K
1.8%
RAPP Rapport Therapeutics, Inc.
15 Apr 2025
Chief Scientific Officer
Sold on a plan
8,500
$81.31K
1.8%
RAPP Rapport Therapeutics, Inc.
14 Mar 2025
Chief Scientific Officer
Sold on a plan
8,500
$92.21K
1.8%
13 decisions on file.